mRNA flu vaccine mFlusiva faces its FDA decision deadline today. Approval will not automatically trigger insurance coverage ...
Health Canada has given Moderna the green light to launch a clinical trial for a vaccine targeting the Bundibugyo form of the ...
Lynch syndrome is an inherited condition and increases the risk of cancers such as prostate, colorectal, ovarian, endometrial ...
RNA-based cancer vaccine research is at a pivotal stage, with early findings suggesting these vaccines can generate ...
The team at University Hospitals, in collaboration with Celloram, Inc. who developed the vaccine technology, is now planning ...
One of the beneficial characteristics of the response to the COVID-19 pandemic were pledges from companies involved in developing vaccines (such ...
The drugmaker’s top line continues to be heavily influenced by Covid vaccine sales.
Scientists are advancing multiple vaccine candidates against the Sudan strain of the Ebola virus, raising prospects for improved ...
The US Food and Drug Administration on Wednesday approved the United States’ first mRNA-based flu vaccine for adults 50 and ...
The Food and Drug Administration on Wednesday approved the first mRNA flu vaccine, enabling use of a technology that will ...
The Food and Drug Administration on Wednesday approved the U.S.’s first flu shot that uses mRNA technology: mFlusiva, from ...
The U.S. Food and Drug Administration has approved a new seasonal flu vaccine from Moderna that uses mRNA technology, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results